I-Mab ADR (IMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMAB | NMRA | BIOA | ||
| Company | I-Mab ADR | Neumora Therapeutics Inc | Bioage Labs Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.70 | 2.27 | 10.44 | ||
| High | 4.77 | 2.30 | 11.20 | ||
| Low | 4.49 | 2.21 | 10.24 | ||
| Latest | 4.63 | 2.22 | 11.16 | ||
| Change | -0.01 | -0.06 | +0.66 | ||
| % Change | -0.22% | -2.63% | +6.29% | ||
| Volume | 1,517,300 | 262,986 | 332,061 | ||
| 20-Day Average Volume | 2,165,250 | 1,138,479 | 278,927 | ||
| Previous Close | 4.64 | 2.28 | 10.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.00 | 2.46 | 8.67 | ||
| 20-Day Raw Stochastic | 25.00% | 12.78% | 100.00% | ||
| 20-Day Relative Strength | 50.83 | 47.28 | 74.51 | ||
| Weighted Alpha | +111.30 | -39.66 | +96.20 | ||
| Today's Opinion | 80% Buy | 64% Buy | 100% Buy | ||
| Previous Opinion | 80% Buy | 80% Buy | 100% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.94% since 10/22/25 | -1.12% since 11/28/25 | +16.54% since 11/28/25 | ||
| Low | 4.13 on 10/24/25 | 2.13 on 12/03/25 | 8.46 on 12/02/25 | ||
| High | 4.88 on 10/28/25 | 2.59 on 12/01/25 | 11.06 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | +35.38% since 09/29/25 | -15.46% since 11/05/25 | +47.47% since 11/05/25 | ||
| Low | 3.46 on 09/30/25 | 2.10 on 11/24/25 | 6.75 on 11/07/25 | ||
| High | 6.79 on 10/16/25 | 3.00 on 11/12/25 | 11.06 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +172.35% since 07/29/25 | +31.85% since 09/05/25 | +132.35% since 09/05/25 | ||
| Low | 1.75 on 07/30/25 | 1.42 on 09/17/25 | 4.68 on 09/16/25 | ||
| High | 6.79 on 10/16/25 | 3.25 on 10/31/25 | 11.06 on 12/05/25 | ||
| 6-Month | |||||
| %Chg | +470.20% since 04/29/25 | +173.42% since 06/05/25 | +149.10% since 06/05/25 | ||
| Low | 0.81 on 04/30/25 | 0.72 on 06/30/25 | 4.07 on 07/01/25 | ||
| High | 6.79 on 10/16/25 | 3.25 on 10/31/25 | 11.06 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 378,086 | 380,128 | 376,477 | ||
| Shares Outstanding, K | 81,660 | 167,089 | 35,855 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -22,230,000 | -243,790,000 | -71,110,000 | ||
| Last Quarter Sales | 0 | 0 | 2,050,000 | ||
| Last Quarter Net Income | -5,500,000 | -56,760,000 | -20,170,000 | ||
| 60-Month Beta | 1.45 | 3.12 | 1.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/20/25 | -0.35 on 11/06/25 | -0.56 on 11/06/25 | ||
| Latest Earnings Date | 11/13/25 | 11/11/25 | 11/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||